StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report released on Saturday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Global Cord Blood stock opened at $1.75 on Friday. The firm has a 50-day moving average of $1.58 and a 200-day moving average of $1.36. The company has a market cap of $212.71 million, a price-to-earnings ratio of 2.73 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50.
Global Cord Blood Company Profile
Featured Stories
- Five stocks we like better than Global Cord Blood
- How to Invest in Small Cap StocksÂ
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- What Are Dividend Challengers?
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What is a Secondary Public Offering? What Investors Need to Know
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.